It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Synthesis of eukaryotic ribosomes involves the assembly and maturation of precursor particles (pre-ribosomal particles) containing ribosomal RNA (rRNA) precursors, ribosomal proteins (RPs) and a plethora of assembly factors (AFs). Formation of the earliest precursors of the 60S ribosomal subunit (pre-60S r-particle) is among the least understood stages of ribosome biogenesis. It involves the Npa1 complex, a protein module suggested to play a key role in the early structuring of the pre-rRNA. Npa1 displays genetic interactions with the DExD-box protein Dbp7 and interacts physically with the snR190 box C/D snoRNA. We show here that snR190 functions as a snoRNA chaperone, which likely cooperates with the Npa1 complex to initiate compaction of the pre-rRNA in early pre-60S r-particles. We further show that Dbp7 regulates the dynamic base-pairing between snR190 and the pre-rRNA within the earliest pre-60S r-particles, thereby participating in structuring the peptidyl transferase center (PTC) of the large ribosomal subunit.
The molecular events underlying the assembly and maturation of the early pre-60S particles during eukaryotic ribosome synthesis are not well understood. Here, the authors combine yeast genetics and biochemical experiments to characterise the functions of two important players of eukaryotic ribosome biogenesis, the box C/D snoRNP snR190 and the helicase Dbp7, which both interact. They show that the snR190 snoRNA acts as a RNA chaperone that assists the structuring of the 25S rRNA during the maturation of early pre-60S particles and that Dbp7 is important for facilitating remodeling events in the peptidyl transferase center region of the 25S rRNAs during the maturation of early pre-60S particles.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Université de Toulouse, CNRS, UPS, Molecular, Cellular and Developmental Biology Unit (MCD), Centre de Biologie Intégrative (CBI), Toulouse, France (GRID:grid.15781.3a) (ISNI:0000 0001 0723 035X); Lebanese University, Genomic Stability and Biotherapy (GSBT) Laboratory, Faculty of Sciences, Rafik Hariri Campus, Beirut, Lebanon (GRID:grid.411324.1) (ISNI:0000 0001 2324 3572); Cancer Research Center of Lyon (CRCL), Lyon, France (GRID:grid.462282.8) (ISNI:0000 0004 0384 0005)
2 Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922); Universidad de Sevilla, Departamento de Genética, Facultad de Biología, Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229)
3 Université de Toulouse, CNRS, UPS, Molecular, Cellular and Developmental Biology Unit (MCD), Centre de Biologie Intégrative (CBI), Toulouse, France (GRID:grid.15781.3a) (ISNI:0000 0001 0723 035X)
4 Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922)
5 Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922); Universidad de Sevilla, Departamento de Microbiología, Facultad de Biología, Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229)
6 Newcastle University, Institute for Cell and Molecular Biosciences, The Medical School, Newcastle upon Tyne, UK (GRID:grid.1006.7) (ISNI:0000 0001 0462 7212)
7 University Medical Centre Göttingen, Department of Molecular Biology, Göttingen, Germany (GRID:grid.411984.1) (ISNI:0000 0001 0482 5331)
8 University Medical Centre Göttingen, Department of Molecular Biology, Göttingen, Germany (GRID:grid.411984.1) (ISNI:0000 0001 0482 5331); Georg-August University Göttingen, Göttingen Center for Molecular Biosciences, Göttingen, Germany (GRID:grid.7450.6) (ISNI:0000 0001 2364 4210)
9 Lebanese University, Genomic Stability and Biotherapy (GSBT) Laboratory, Faculty of Sciences, Rafik Hariri Campus, Beirut, Lebanon (GRID:grid.411324.1) (ISNI:0000 0001 2324 3572)